Guidant Responds to Form 483; Emphasizes Part 11 Controls

The GMP Letter
A A

While Guidant said it disagrees with the FDA’s recent observation of apparent software validation and electronic records control violations, the company also noted it would examine and strengthen relevant in-house requirements and implementation guidelines to ensure compliance with 21 CFR Part 11.

To View This Article:

Login

Subscribe To The GMP Letter

Buy This Article Now

Add this article to your cart for $10.00